Malawi researchers to tap into GSK’s £4m for cancer, diabetes
Health researchers from Malawi are in line to tap from a £4m first round of funding that one of the world’s leading pharmaceuticals firms GSK has made available for eight African countries to research into non-communicable diseases (NCDs) such as cancer, diabetes and chronic kidney disease. GSK said on Friday it has launched the first call for proposals for its...
Read More